SCHEMBL7252877

SCHEMBL7252877

O=C1C(=Cc2cccc(C(F)(F)F)c2)SC(c2cccc(Cl)c2)N1CCCN1CCN(c2ccccn2)CC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.43
DRD3 P35462 8/20 0.43
DRD1 P21728 1/20 0.43
DRD4 P21917 11/20 0.42
HTR7 P34969 8/20 0.42
HTR1A P08908 7/20 0.42
HTR2A P28223 7/20 0.42
HTR2C P28335 7/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SLC6A4 P31645 1/20 0.42
MAPT P10636 2/20 0.41
TSHR P16473 1/20 0.41
ADRA1A P35348 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7252876 1.00 DRD2 (0.43) DRD2DRD3DRD1DRD4HTR7
SCHEMBL7252865 0.93 DRD4 (0.47) DRD2DRD3DRD1DRD4HTR7
SCHEMBL7252863 0.93 DRD4 (0.47) DRD2DRD3DRD1DRD4HTR7
SCHEMBL7254598 0.92 HTR7 (0.40) DRD2DRD3DRD1HTR7HTR1A
SCHEMBL7254595 0.92 HTR7 (0.40) DRD2DRD3DRD1HTR7HTR1A
SCHEMBL7251894 0.92 DRD3 (0.47) DRD2DRD3DRD1HTR7HTR1A
SCHEMBL7251895 0.92 DRD3 (0.47) DRD2DRD3DRD1HTR7HTR1A
SCHEMBL7248267 0.91 DRD4 (0.47) DRD2DRD3DRD4HTR7HTR1A
SCHEMBL7248265 0.91 DRD4 (0.47) DRD2DRD3DRD4HTR7HTR1A
SCHEMBL7254175 0.90 HTR7 (0.46) DRD2DRD3DRD1DRD4HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US claimed